본문 바로가기

Dual (thermo-/pH-) responsive P(NIPAM-co-AA-co-HEMA) nanocapsules for controlled release of 5-fluorouracil

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q3Scopus Q2
피인용
Web of Science 16Scopus 16
FWCI (Scopus)
0.73
JCR IF
JCR 2020 2.168
ISSN
1060-1325

저자

  1. 장 웨이진제1저자Pusan Natl Univ, Sch Chem Engn, Dept Polymer Sci & Engn, Busan 46241, South Korea
  2. 옌융주Pusan Natl Univ, Sch Chem Engn, Dept Polymer Sci & Engn, Busan 46241, South Korea
  3. 나가빤 사르와난Pusan Natl Univ, Sch Chem Engn, Dept Polymer Sci & Engn, Busan 46241, South Korea
  4. 허 산산Pusan Natl Univ, Sch Mech Engn, Engn Precis Mfg Syst Div, Busan, South Korea
  5. 하창식교신저자Pusan Natl Univ, Sch Chem Engn, Dept Polymer Sci & Engn, Busan 46241, South Korea
  6. Jin, Yu-Shun교신저자Beijing Inst Petrochem Technol, Sch Mat Sci & Engn, Beijing Key Lab Special Elastomer Composites, Beijing 102617, Peoples R China

초록

© 2021 Taylor & Francis Group, LLC.Dual-responsive nanocapsules of poly (N-isopropyl acrylamide (NIPAM)-co-acrylic acid (AA)-co-2-hydroxyethylmethacrylate (HEMA)) were synthesized by precipitation polymerization. The dual (temperature- and pH-)-responsive nanocapsules were fabricated using NIPAM as a temperature-sensitive monomer, AA as a pH-responsive monomer and 5-fluorouracil (5-FU) as a model drug. The P(NIPAM-co-AA-co-HEMA) nanocarrier had a hollow nanocapsule structure with average diameter of about 70 nm and a shell thickness of about 10 nm. The nanocarrier exhibited good loading capacity (32.6%) and considerable encapsulation efficiency (57.3%) for 5-FU by physical entrapment. The zeta potentials of nanocapsules were observed from −30.7 to −35.2 mV after the incorporation of 5-FU. The cumulative release of nanocapsules reached at 88.7% (37 °C, pH 5.8). The overall drug release performance revealed that the drug release behavior was efficient, sustainable and stable at 37 °C and pH 7.4. In addition, the release mechanism analysis suggested that the drug release behavior is more dependent on pH than temperature.

키워드

5-fluorouracildrug releaseencapsulation efficiencyNanocapsulesstimuli responsivenessMESOPOROUS SILICA NANOPARTICLESDRUG-DELIVERYIN-VITROMICROFLUIDIC PRODUCTIONINTRACELLULAR UPTAKEMULTIPLE EMULSIONSTRIGGERED-RELEASEANTICANCER DRUGSCANCER-CELLSPH

식별자

Scopus EID
2-s2.0-85112533431
WoS UID
000685326500001